Good Morning. Thank you for the opportunity to provide testimony on the current
HIV/AIDS epidemic and CDC's current efforts to prevent the further spread of HIV in
this country.
The HIV/AIDS epidemic has changed considerably since it was first described in the
United States in 1981. After a decade and a half of steady increase, we witnessed our
first decrease in AIDS incidence and AIDS deaths in 1996. AIDS- related deaths
decreased 42% from 1996 to 1997 and 20% from 1997 to 1998. AIDS incidence
decreased 18% from 1996 to 1997 and 11% from 1997 to 1998. These data supports the
effectiveness of the new highly active antiretroviral therapy (HAART) that was
introduced around the time of these initial declines. The relative greater decline in AIDS
deaths compared with AIDS cases has resulted in a 10% increase in the number of
persons living with AIDS from the end of 1997 to the end of 1998. More recently there is
evidence of a slowing in the decrease in AIDS cases and deaths that may indicate
growing treatment failures and lack of access to therapy for a substantial number of
people. Change has also occurred in the number of new HIV infections from a high of
approximately 150,000 new infections a year in the mid to late 1980s to a plateau of
approximately 40,000 new infections a year today. There are an estimated 900,000
persons living with HIV and approximately 250,000 are unaware of their seropositive
status.
The demographics of the HIV/AIDS epidemic have changed considerably as well. The
proportion of AIDS cases in white men who have sex with men (MSM) declined,
whereas the proportion in men and women of color (especially African Americans and
Hispanics) has increased. Fifty percent new HIV infections occur in people under 25.
Women now account for 30% of new HIV infections; 64% are African American
women. African Americans and Hispanics comprise 54% and 19% of new HIV
infections respectively. African American and Latino men represent 51% of reported
AIDS cases among MSM.
Early prevention activities were targeted to communities initially most affected by the
epidemic, primarily gay men and injection drug users (IDUs) as well as the general
population that needed information about a new disease threat. As the epidemic has
expanded to more diverse communities, CDC's efforts have also expanded accordingly to
reach a broader target audience including communities of color (especially African
Americans and Latinos), gay men of color, persons living with HIV, youth (especially
young gay men), women (including pregnant women), individuals with STDs and
communities with high STD prevalence, and incarcerated persons.
The success of HAART is encouraging, but the availability of new, more effective
treatments may lead people to believe that HIV prevention is no longer important. HIV
prevention efforts have resulted in behavior change, but studies show that high-risk
behaviors (especially unprotected sex) are re-emerging. We estimate approximately five
million persons are at behavioral risk for HIV infection right now. Consequently,
complacency about the need for HIV prevention has now become one of our biggest
barriers and challenges.
I would like to highlight three studies that show the significance of complacency in the
U.S. and why CDC is so concerned. A study conducted in San Francisco between 1994
and 1997 among a multiracial/ethnic group of MSM showed decreases in consistent
condom use, increases in the proportion engaging in unprotected anal sex with multiple
partners and increase in the incidence of rectal gonorrhea. MSM reporting having anal
sex increased from 57.6% in 1994 to 61.2% in 1997. Those reporting having anal sex
and "always" using a condom declined from 69.6% in 1994 to 60.8% in 1997. Men
reporting having multiple sex partners and unprotected anal intercourse increased from
23.6% in 1994 to 33.3% in 1997. The largest increase, from 22.0% to 32.1% was seen
for men 25 years or less. This study also shows that men who had unprotected anal sex
with men and had multiple partners did not know the HIV serostatus of all their partners.
Additionally, rectal gonorrhea incidence increased from 21 to 38 per 100,000 adult men.
This increase in incidence was observed in all races and age groups.
The second study was conducted by the Seattle-King County health department from
1997 to 1999 and showed a major increase in infectious syphilis, chlamydia and
gonorrhea among MSM in King County from 1997 to June 1999. For example, the
annual rate of infectious syphilis per 100,000 MSM increased from zero in 1996 to
approximately 10 in 1997 and 90 in 1998, and the projected annual incidence in 1999
was 200 cases per 100,000. There was also an increase in chlamydia and gonorrhea
during this period among MSM attending King County ST D clinics. The majority of the
men in this study reported likely exposure to STDs through anonymous partners. The
high proportion of persons with STDs, is of major concern given the two to fivefold
increased risk of HIV infection associated with presence of another STD. Control of
STDs is a central component of HIV infection prevention efforts and the resurgence of
bacterial STDs threatens national HIV infection prevention efforts.
Recently, we reported on a seven-state study conducted by CDC between July 1998 and
February 1999 that found 31% of 1,976 HIV-negative or untested individuals at risk for
HIV infection were "less concerned" about becoming infected because of new HIV
treatments. The 31% reporting this behavior in the survey included the following by risk
group: 40% were injection drug users, 30% were heterosexuals, and 25% were gay and
bisexual men. 17% of the 1,976 HIV-negative or untested individuals at risk for HIV
infection were "less safe" about sex or drug use because of new HIV treatments. The
17% reporting this behavior by risk group included: 25% injection drug users, 15%
heterosexuals, and 13% gay and bisexual men.
At CDC, we continue to strengthen our efforts to decrease HIV transmission through
comprehensive strategies including surveillance, research, prevention, policy
development, and evaluation. The centerpiece of our collaboration with state and local
jurisdictions is the community planning process. The community voice is essential when
setting prevention priorities and assuring that funds are following the epidemiolgy and
the interventions are relevant to a given community. Progress has been made over time
in making the community planning process and the resultant targeting of resources
representative of the communities most affected and their prevention needs. However,
more progress still needs to be made. The largest single expenditure category for
prevention services through community planning is for health education and risk
reduction (HERR) services, approximately 39%. In 1998, for HERR, 31% of resources
were targeted to African Americans, 3% to Asian American, 20% to Hispanics, 2% to
Native Americans and 23% to whites . For the comparable year, 43% of AIDS cases
were among African American, <1% Asian Pacific Islanders, 20% Hispanics, <1%
Native Americans, and 35% whites. Nationally, the race/ethnic composition for
community planning groups (CPGs) in 1998 was 27% African American , 3%
Asian/Pacific Islander, 12% Hispanic, 5% Native American and 53% White. Male and
female representation is equal. Youth <24 years made up only less 5% of CPG
membership.
Given the importance of broad and diverse involvement in HIV prevention, CDC has
expanded its alliances beyond its traditional public health partners to include, community
based and other non-governmental organizations, faith-based organizations, correctional
facilities, health care facilities (including managed care organizations), national minority
organizations, business and labor sectors, schools and youth organizations, and
substance abuse prevention and treatment programs.
We now know more than ever what works in prevention and are increasing our efforts to
translate the best prevention into program implementation using a comprehensive mix of
proven prevention strategies such as individual counseling, small group interventions,
community-level interventions, social/prevention marketing, prevention case
management, structural interventions, HIV counseling and testing and partner counseling
and referral services, STD treatment, media campaigns, public information, hotlines and
improved linkages to HIV and substance abuse treatment. While continuing efforts to
prevent infection in people at greatest risk, we also are focusing more attention to
prevention efforts for those already infected with HIV.
To do our job well we need investment in prevention and support for strong policies that
reinforce sound science and public health intervention. There are many continuing
challenges to face in our efforts to prevent the HIV/AIDS pandemic: HIV stigma,
homophobia, unequal access to health services, policies that limit proven public health
intervention, gender inequities and lack of female controlled options for prevention, and
perhaps most troubling, complacency. This complacency is occurring among individuals,
communities and the wider society. We must combat complacency at all levels if we
hope to make the impact we all want on reducing the number of new infections in this
country and throughout the world.
Thank you for your time and I look forward to working with you and other members of
Congress in a bipartisan effort to improve access and treatment to HIV prevention
services.
HHS Home (www.hhs.gov) |
Topics (www.hhs.gov/SiteMap.html) |
What's New (www.hhs.gov/about/index.html#topiclist) |
For Kids (www.hhs.gov/kids/) |
FAQs (answers.hhs.gov) |
Site Info (www.hhs.gov/SiteMap.html) |
Disclaimers (www.hhs.gov/Disclaimer.html) |
Privacy Notice (www.hhs.gov/Privacy.html) |
FOIA (www.hhs.gov/foia/) |
Accessibility (www.hhs.gov/Accessibility.html) |
Contact Us (www.hhs.gov/ContactUs.html)